The Globe and Mail reports in its Thursday, Feb. 15, edition that Raymond James analyst Stephen Boland is maintaining his "outperform" recommendation for Intact Financial. The Globe's David Leeder writes in the Eye On Equities column that Mr. Boland boosted his share target by a lofty $26 to $247. Analysts on average target the shares at $227.13. Mr. Boland says in a note: "Intact reported their 4Q23 results [Tuesday] night. Overall, this was a very strong quarter despite the benefit of lower cat losses across property lines. Intact reported NOIPS of $4.22 vs consensus of $3.38 and RJL at $3.75. Performance was strong across most segments, with the exception of UK lines which saw elevated cat losses this quarter. The outlook for 2024 remains largely unchanged, with firm-to-hard market conditions expected across all lines. In a notable positive, UK lines are now expected to deliver a low-90's combined ratio in 2024, reflecting recent strategic actions taken and the exit of UKI personal lines. The UK commercial market could be a focus for Intact over the next 12 to 24 months, with the company's relatively low market share offering plenty of runway for organic expansion and M&A."